Clinical Trial Update: Omitting Clinical Target Volume in Radical Treatment of Unresectable Stage III Non-small Cell Lung Cancer

View source ↗

Summary

Clinical trial update evaluating omission of the clinical target volume in radical treatment for unresectable stage III non-small cell lung cancer; the study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Xinqiao Hospital of Chongqing | Conditions: Immunotherapy, Intensity Modulated Radiation Therapy | Status: NOT_YET_RECRUITING